{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:22:43Z","timestamp":1787703763166,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403429"],"award-info":[{"award-number":["82403429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103052"],"award-info":[{"award-number":["82103052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072662"],"award-info":[{"award-number":["82072662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04452-x","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:14:04Z","timestamp":1781669644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serological signatures and pathological features for the management of CEA-negative colorectal cancer: development of combined diagnostic and prognostic nomograms"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhongmao","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"3","key":"4452_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA-Cancer J Clin"},{"issue":"2","key":"4452_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344.","journal-title":"Gut"},{"issue":"3","key":"4452_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA-Cancer J Clin. 2023;73(3):233\u201354.","journal-title":"CA-Cancer J Clin"},{"key":"4452_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijsu.2019.02.014","volume":"64","author":"AR Baqar","year":"2019","unstructured":"Baqar AR, Wilkins S, Staples M, Lee CHA, Oliva K, McMurrick P. The role of preoperative CEA in the management of colorectal cancer: A cohort study from two cancer centres. Int J Surg. 2019;64:10\u20135.","journal-title":"Int J Surg"},{"issue":"3","key":"4452_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/jamaoncol.2017.4420","volume":"4","author":"T Konishi","year":"2018","unstructured":"Konishi T, Shimada Y, Hsu M, Tufts L, Jimenez-Rodriguez R, Cercek A, et al. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome. JAMA Oncol. 2018;4(3):309\u201315.","journal-title":"JAMA Oncol"},{"issue":"3","key":"4452_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ijrobp.2008.08.057","volume":"74","author":"JW Park","year":"2009","unstructured":"Park JW, Lim SB, Kim DY, Jung KH, Hong YS, Chang HJ, et al. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery. Int J Radiat Oncol Biol Phys. 2009;74(3):810\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4452_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/annonc\/mds336","volume":"24","author":"C Aggarwal","year":"2013","unstructured":"Aggarwal C, Meropol NJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, et al. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann Oncol. 2013;24(2):420\u20138.","journal-title":"Ann Oncol"},{"issue":"3","key":"4452_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/DCR.0000000000002655","volume":"66","author":"M Paku","year":"2023","unstructured":"Paku M, Uemura M, Kitakaze M, Miyoshi N, Takahashi H, Mizushima T, et al. Clinical Significance of Preoperative and Postoperative Serum CEA and Carbohydrate Antigen 19\u2009\u2013\u20099 Levels in Patients Undergoing Curative Resection of Locally Recurrent Rectal Cancer. Dis Colon Rectum. 2023;66(3):392\u2013400.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"4452_CR9","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1245\/s10434-019-07184-3","volume":"26","author":"SH Huang","year":"2019","unstructured":"Huang SH, Tsai WS, You JF, Hung HY, Yeh CY, Hsieh PS, et al. Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis. Ann Surg Oncol. 2019;26(6):1685\u201394.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4452_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41598-023-49832-5","volume":"13","author":"GM Ren","year":"2023","unstructured":"Ren GM, Li RK, Zheng GZ, Du KL, Dan HJ, Wu HZ, et al. Prognostic value of normal levels of preoperative tumor markers in colorectal cancer. Sci Rep. 2023;13(1):12.","journal-title":"Sci Rep"},{"issue":"1","key":"4452_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/DCR.0000000000002894","volume":"67","author":"YJ Chern","year":"2024","unstructured":"Chern YJ, Hsu HY, Hsu YJ, Hsu LY, Tsai WS, Liao CK, et al. Tumor Marker Trajectories and Survival Analysis in Patients With Normal Carcinoembryonic Antigen Ranges After Colorectal Cancer Resection. Dis Colon Rectum. 2024;67(1):62\u201372.","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"4452_CR12","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/jama.2016.11212","volume":"316","author":"BD Nicholson","year":"2016","unstructured":"Nicholson BD, Shinkins B, Mant D. Blood Measurement of Carcinoembryonic Antigen Level for Detecting Recurrence of Colorectal Cancer. JAMA-J Am Med Assoc. 2016;316(12):1310\u20131.","journal-title":"JAMA-J Am Med Assoc"},{"issue":"11","key":"4452_CR13","doi-asserted-by":"publisher","first-page":"E493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):E493\u2013503.","journal-title":"Lancet Oncol"},{"issue":"2","key":"4452_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00408-017-9976-6","volume":"195","author":"L Kasmann","year":"2017","unstructured":"Kasmann L, Bolm L, Schild SE, Janssen S, Rades D. Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer. Lung. 2017;195(2):217\u201324.","journal-title":"Lung"},{"issue":"11","key":"4452_CR15","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1007\/s00262-023-03513-4","volume":"72","author":"ZF Zhang","year":"2023","unstructured":"Zhang ZF, Wang DZ, Zhang JJ, Ruan YL, Zhao L, Yang L, et al. Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score. Cancer Immunol Immunother. 2023;72(11):3635\u201349.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"4452_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4143\/crt.2020.330","volume":"53","author":"L Fang","year":"2021","unstructured":"Fang L, Yan FH, Liu C, Chen J, Wang D, Zhang CH, et al. Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer. Cancer Res Treat. 2021;53(1):131\u20139.","journal-title":"Cancer Res Treat"},{"issue":"7","key":"4452_CR17","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/s41416-020-01254-0","volume":"124","author":"AM Starzer","year":"2021","unstructured":"Starzer AM, Steindl A, Mair MJ, Deischinger C, Simonovska A, Widhalm G, et al. Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. Br J Cancer. 2021;124(7):1294\u2013300.","journal-title":"Br J Cancer"},{"issue":"1","key":"4452_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cncr.31778","volume":"125","author":"MA Bilen","year":"2019","unstructured":"Bilen MA, Martini DJ, Liu Y, Lewis C, Collins HH, Shabto JM, et al. The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy. Cancer. 2019;125(1):127\u201334.","journal-title":"Cancer"},{"key":"4452_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lungcan.2019.08.006","volume":"136","author":"F Shoji","year":"2019","unstructured":"Shoji F, Takeoka H, Kozuma Y, Toyokawa G, Yamazaki K, Ichiki M, et al. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Lung Cancer. 2019;136:45\u201351.","journal-title":"Lung Cancer"},{"issue":"4","key":"4452_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11523-019-00660-6","volume":"14","author":"H Ishihara","year":"2019","unstructured":"Ishihara H, Tachibana H, Takagi T, Kondo T, Fukuda H, Yoshida K, et al. Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma. Target Oncol. 2019;14(4):453\u201363.","journal-title":"Target Oncol"},{"key":"4452_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fonc.2023.1279487","volume":"13","author":"H Cai","year":"2023","unstructured":"Cai H, Li JC, Chen Y, Zhang Q, Liu Y, Jia HJ. Preoperative inflammation and nutrition-based comprehensive biomarker for predicting prognosis in resectable colorectal cancer. Front Oncol. 2023;13:9.","journal-title":"Front Oncol"},{"issue":"7","key":"4452_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijms24076753","volume":"24","author":"K Lehtom\u00e4ki","year":"2023","unstructured":"Lehtom\u00e4ki K, Heerv\u00e4 E, Kellokumpu-Lehtinen PL, Mustonen H, Salminen T, Joensuu H, et al. Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer. Int J Mol Sci. 2023;24(7):17.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4452_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12885-023-10585-z","volume":"23","author":"H Zhang","year":"2023","unstructured":"Zhang H, Lin F, Wang ZC. Mean platelet volume\/platelet count ratio in combination with tumor markers in colorectal cancer: a retrospective clinical study. BMC Cancer. 2023;23(1):8.","journal-title":"BMC Cancer"},{"issue":"2","key":"4452_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10350-003-0041-6","volume":"47","author":"S Morita","year":"2004","unstructured":"Morita S, Nomura T, Fukushima Y, Morimoto T, Hiraoka N, Shibata N. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer? Dis Colon Rectum. 2004;47(2):227\u201332.","journal-title":"Dis Colon Rectum"},{"key":"4452_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ebiom.2021.103706","volume":"74","author":"CX Li","year":"2021","unstructured":"Li CX, Zhang DF, Pang XL, Pu HJ, Lei M, Fan BB, et al. Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study. EBioMedicine. 2021;74:8.","journal-title":"EBioMedicine"},{"issue":"1","key":"4452_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-023-02773-2","volume":"21","author":"CX Li","year":"2023","unstructured":"Li CX, Zhao K, Zhang DF, Pang XL, Pu HJ, Lei M, et al. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study. BMC Med. 2023;21(1):13.","journal-title":"BMC Med"},{"key":"4452_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41598-018-21048-y","volume":"8","author":"YF Gao","year":"2018","unstructured":"Gao YF, Wang JP, Zhou Y, Sheng S, Qian SY, Huo XW. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Sci Rep. 2018;8:9.","journal-title":"Sci Rep"},{"issue":"6","key":"4452_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/bjc.1987.137","volume":"55","author":"P Kuusela","year":"1987","unstructured":"Kuusela P, Haglund C, Roberts PJ, Jalanko H, Comparison of, ca-50. a new tumor-marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal-diseases. Br J Cancer. 1987;55(6):673\u20136.","journal-title":"Br J Cancer"},{"key":"4452_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/srep46345","volume":"7","author":"QG Li","year":"2017","unstructured":"Li QG, Dai WX, Li YQ, Xu Y, Li XX, Cai SJ. Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection. Sci Rep. 2017;7:10.","journal-title":"Sci Rep"},{"issue":"23","key":"4452_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/cancers15235643","volume":"15","author":"X Dai","year":"2023","unstructured":"Dai X, Wang HR, Lu YQ, Chen Y, Liu Y, Huang SY. Development and Validation of a Nomogram to Predict Overall Survival in Stage I-III Colorectal Cancer Patients after Radical Resection with Normal Preoperative Serum Carcinoembryonic Antigen. Cancers. 2023;15(23):16.","journal-title":"Cancers"},{"issue":"15","key":"4452_CR31","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.7150\/jca.58887","volume":"12","author":"TF Li","year":"2021","unstructured":"Li TF, Yu ZK, Yang Y, Fu ZM, Chen ZA, Li Q, et al. Rapid multi-dynamic algorithm for gray image analysis of the stroma percentage on colorectal cancer. J Cancer. 2021;12(15):4561\u201373.","journal-title":"J Cancer"},{"issue":"11","key":"4452_CR32","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1002\/cam4.1814","volume":"7","author":"GJ Tong","year":"2018","unstructured":"Tong GJ, Xu W, Zhang GY, Liu J, Zheng ZZ, Chen Y, et al. The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study. Cancer Med. 2018;7(11):5327\u201338.","journal-title":"Cancer Med"},{"issue":"1","key":"4452_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41598-024-55967-w","volume":"14","author":"HJ Pu","year":"2024","unstructured":"Pu HJ, Yang W, Liu MM, Pang XL, Chen YX, Xiong QX. Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study. Sci Rep. 2024;14(1):13.","journal-title":"Sci Rep"},{"issue":"1","key":"4452_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/1724600818820679","volume":"34","author":"W Ramphal","year":"2019","unstructured":"Ramphal W, Boeding JRE, van Iwaarden M, Schreinemakers JMJ, Rutten HJT, Crolla R, et al. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer. Int J Biol Markers. 2019;34(1):60\u20138.","journal-title":"Int J Biol Markers"},{"issue":"11","key":"4452_CR35","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1007\/s10350-004-6810-z","volume":"46","author":"R Palmqvist","year":"2003","unstructured":"Palmqvist R, Engar\u00e5s B, Lindmark G, Hallmans G, Tavelin B, Nilsson O, et al. Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer:: A matched case-control study. Dis Colon Rectum. 2003;46(11):1538\u201344.","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"4452_CR36","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1245\/s10434-020-08256-5","volume":"27","author":"SH Beom","year":"2020","unstructured":"Beom SH, Shin SJ, Kim CG, Kim JH, Hur H, Min BS, et al. Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection. Ann Surg Oncol. 2020;27(8):2774\u201383.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4452_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/bjc.2015.202","volume":"113","author":"DS Thomas","year":"2015","unstructured":"Thomas DS, Fourkala EO, Apostolidou S, Gunu R, Ryan A, Jacobs I, et al. Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. Br J Cancer. 2015;113(2):268\u201374.","journal-title":"Br J Cancer"},{"issue":"7","key":"4452_CR38","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/cam4.692","volume":"5","author":"VI Butvilovskaya","year":"2016","unstructured":"Butvilovskaya VI, Popletaeva SB, Chechetkin VR, Zubtsova ZI, Tsybulskaya M, Samokhina LO, et al. Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips. Cancer Med. 2016;5(7):1361\u201372.","journal-title":"Cancer Med"},{"issue":"13","key":"4452_CR39","doi-asserted-by":"publisher","first-page":"14636","DOI":"10.1002\/cam4.6067","volume":"12","author":"R Zhao","year":"2023","unstructured":"Zhao R, Xia DG, Chen YW, Kai ZT, Ruan FY, Xia CR, et al. Improved diagnosis of colorectal cancer using combined biomarkers including\u2009<\u2009i>Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19-9, gender, and age. Cancer Med. 2023;12(13):14636\u201345.","journal-title":"Cancer Med"},{"issue":"10","key":"4452_CR40","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/bjc.2017.96","volume":"116","author":"S Ghuan","year":"2017","unstructured":"Ghuan S, Van Hemelrijck M, Garmo H, Holmberg L, Malmstr\u00f6m H, Lambe M, et al. Serum inflammatory markers and colorectal cancer risk and survival. Br J Cancer. 2017;116(10):1358\u201365.","journal-title":"Br J Cancer"},{"issue":"3","key":"4452_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3171\/2017.3.JNS161648","volume":"129","author":"SH Zheng","year":"2018","unstructured":"Zheng SH, Huang JL, Chen M, Wang BL, Ou QS, Huang SY. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study. J Neurosurg. 2018;129(3):583\u201392.","journal-title":"J Neurosurg"},{"key":"4452_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2020\/8844698","volume":"2020","author":"XM Zhu","year":"2020","unstructured":"Zhu XM, Song HZ, Chen Y, Han FF, Wang Q, Cui YB. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Blood to Distinguish Lung Cancer Patients from Healthy Subjects. Dis Markers. 2020;2020:5.","journal-title":"Dis Markers"},{"issue":"1","key":"4452_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12935-022-02532-y","volume":"22","author":"HQ Ying","year":"2022","unstructured":"Ying HQ, Chen W, Xiong CF, Wang YY, Li XJ, Cheng XX. Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer. Cancer Cell Int. 2022;22(1):13.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"4452_CR44","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1002\/jcsm.13358","volume":"14","author":"GT Ruan","year":"2023","unstructured":"Ruan GT, Xie HL, Yuan KT, Lin SQ, Zhang HY, Liu CA, et al. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia. J Cachexia Sarcopenia Muscle. 2023;14(6):2813\u201323.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"16","key":"4452_CR45","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.7150\/jca.31660","volume":"10","author":"WQ You","year":"2019","unstructured":"You WQ, Sheng NQ, Yan L, Chen HQ, Gong JF, He ZH, et al. The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers. J Cancer. 2019;10(16):3757\u201366.","journal-title":"J Cancer"},{"issue":"3","key":"4452_CR46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","volume":"265","author":"JCY Chan","year":"2017","unstructured":"Chan JCY, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, et al. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Ann Surg. 2017;265(3):539\u201346.","journal-title":"Ann Surg"},{"issue":"2","key":"4452_CR47","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/bjc.2013.785","volume":"110","author":"M Stotz","year":"2014","unstructured":"Stotz M, Pichler M, Absenger G, Szkandera J, Arminger F, Schaberl-Moser R, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer. 2014;110(2):435\u201340.","journal-title":"Br J Cancer"},{"issue":"8","key":"4452_CR48","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jamaoncol.2019.0528","volume":"5","author":"T Reinert","year":"2019","unstructured":"Reinert T, Henriksen TV, Christensen E, Sharma S, Salari R, Sethi H, et al. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer. JAMA Oncol. 2019;5(8):1124\u201331.","journal-title":"JAMA Oncol"},{"issue":"24","key":"4452_CR49","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1200\/JCO.21.02615","volume":"40","author":"M Malla","year":"2022","unstructured":"Malla M, Loree JM, Kasi PM, Parikh AR. Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices. J Clin Oncol. 2022;40(24):2846\u201357.","journal-title":"J Clin Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04452-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04452-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04452-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:42:02Z","timestamp":1787701322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04452-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4452"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04452-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study adhered to the Declaration of Helsinki and received approval from the Clinical Research Ethics Committee of Shanghai General Hospital.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"346"}}